Jian Wang
Mengjiao Li- Department of Neurology, Affiliated Aerospace Hospital of Zunyi Medical University, Zunyi, Guizhou, China
Background: Tuberculous meningitis (TBM) with adults Epstein-Barr (EB) virus encephalitis is a very rare infectious disease, with a high mortality and disability. Metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid (CSF) is highly diagnostic. We report on a case of severe meningoencephalitis caused by co-infection with mycobacterium tuberculosis and EB virus. Brain MRI indicated a parenchyma lesion in the brain. mNGS of CSF indicated Mycobacterium tuberculosis and EB virus amplification, positive serum EB virus IgG antibodies, and improved symptoms after anti-tuberculosis and antiviral treatment. A re-examination of the brain MRI revealed that the significantly absorption of the lesions.
Case report: A 49-year-old male patient presented with a chief complaint of headache and fever with consciousness disturbance. The brain magnetic resonance imaging showed a lesions in the right parenchymal brain with uneven enhancement, accompanied by significantly increased intracranial pressure, elevated CSF cell count and protein levels, as well as notably decreased glucose and chloride levels. mNGS of CSF showed the coexistence of Mycobacterium tuberculosis and EBV. The patient was diagnosed as TBM with EBV encephalitis. The patient’s symptoms gradually improved with the active administration of anti-tuberculosis combined with antiviral agents, the use of hormones to reduce inflammatory reaction, dehydration to lower intracranial pressure, and intrathecal injection. Subsequent follow-up brain magnetic resonance imaging indicated significant absorption of the lesions, along with a marked decrease in CSF count and protein levels, as well as obvious increase in glucose and chloride levels.
Conclusion: TBM associated with adult EBV encephalitis is extremely rare. The disease’s early stages are severe and have a high fatality rate. A prompt and accurate diagnosis is particularly important. NGS of CSF is of great value for early diagnosis.
Introduction
Tuberculous meningitis (TBM) is a non-suppurative inflammatory disease of the central nervous system caused by Mycobacterium tuberculosis, with a high mortality and disability rate (Ahlawat et al., 2020). adults Epstein-Barr virus(EBV) encephalitis is a serious infectious disorder of the central nervous system, predominantly observed in children and relatively rare in adults. It poses a perilous threat, with an alarmingly high fatality rate (Baldwin and Cummings, 2018). TBM co-infection with EBV is extremely rare. We hereby reported an analysis and summary of a case of rare severe TBM simultaneously infected with EBV in our hospital.
Case report
We reported a case of a 49-year-old man complaining of headache and fever with impaired consciousness. According to the description of the patient’s family: on October 21,2023, the patient felt headache characterized by a diffuse, persistent pain throughout the entire head. The headache was accompanied by severe nausea and vomiting, which did not alleviate the pain. As well, the administration of oral analgesics failed to provide any relief for the headache. On October 23,2023, the patient began to experience a fever, with the highest body temperature ranging from 39°C to 41°C. Upon self-administration of antipyretic medication ibuprofen, the temperature briefly returned to normal, only to rise again after a few hours. He was diagnosed with purulent meningitis after examination at a local hospital. Treatment included the administration of mannitol dehydration to reduce intracranial pressure, cephalosporin for anti-inflammatory, and fever reduction. However, the specific treatment plan was unknown. The patients complained of persistent headache without obvious alleviation, still frequent vomiting, and continuous fever with temperature fluctuations ranging from 39°C to 41°C. The condition progressively worsened, and the patient exhibited abnormal behavior characterized by incoherent speech and restlessness. On October 28, 2023, the patient presented with impaired consciousness, unresponsive, and in a state of coma. Due to continuous deterioration, he was immediately transferred to our hospital. According to the family, the patient had a history of silicosis for more than 10 years, with occasional difficulty breathing. No special personal or family history was found.
The physical examination revealed a temperature of 40.4°C, a pulse rate of 128 times/min, a respiratory rate of 28 times/min, a blood oxygen saturation of 80% without oxygen supplementation, and a blood pressure of 132/87 mmHg. The patient appeared to be in a state of shallow coma, with diminished sound and moist rales in both lungs. Further examination of the internal medicine was inconclusive. In the neurological examination, the patient was in a state of mild coma, with bilateral pupil round and dilated, measuring approximately 2.5 mm in diameter. He exhibited sensitive response to light stimuli, and displayed a sign of distress during pressure frame reflex. The patient was uncooperative during the cranial nerve examination. Avoidance movement of limbs were observed in response to painful stimuli, and symmetrical limb tendon reflexes were present, with neck rigidity 3 fingers and Kernig sign positive. No pathological signs were elicited.
After admission to our department, the patient received active treatment included endotracheal intubation for assisted ventilator, continuous oxygen inhalation, electroencephalographic(ECG) monitoring of vital signs, administration of mannitol dehydration to reduce intracranial pressure, cephalosporin for anti-infection, and antipyretic. Emergency brain magnetic resonance imaging (MRI) examination showed long T1 and long T2 signal in the right parietal lobe, slightly increased FLAIR signal, high DWI signal, low ADC signal, accompanied by sulcus and gyrus edema. Enhanced scan indicated mild enhancement at the center of the lesion (Figure 1). Lumbar puncture cerebrospinal fluid (CSF) examination demonstrated the increased brain pressure (> 400 mmH2O), elevated CSF cell count and protein levels, and significant decrease in glucose and chloride levels (Table 1). The blood routine test indicated a white blood cell count of 12.51 × 109/L, with nucleated cell percentage of 92.7% and a lymphocyte percentage of 2.5%. The erythrocyte sedimentation rate was 74 mm/h, and C-reactive protein (CRP) level was 132.4 μg/ml. Thereafter, a combination of isoniazid, rifampicin, pyrazinamide and ethambutol was administrated for diagnostic anti-tuberculosis (Isoniazid 0.3 qd, Rifampicin 0.45 qd, Ethambutol 0.75 qd, Pyrazinamide 0.5 tid) treatment, and dexamethasone(15mg/daily ivgtt for 2 weeks) was prescribed to reduced inflammation and edema.
Figure 1. (October 28th,2023) MRI images showed the right parietal lobe long T1 signal (A), long T2 signal (B), slightly increased FLAIR signal (C), high DWI signal (D), low ADC signal (E), and sulcus gyrus edema. Enhanced MRI images (F–H) showed uneven enhancement in the right parietal lobe.
Table 1. CSF of laboratory results.
After 3 days of continuous treatment, the patient still experienced recurrent high fever and continuous coma. The video electroencephalogram indicated diffuse slow wave distribution. Further CSF and serum autoimmune encephalitis antibodies detection demonstrated the negative of MOG, GFAP, and AQP 4 antibodies. However, the serum EBV-IgG antibody was positive, whereas the tuberculosis antibody was negative. In addition, the repeated CSF antacid staining, cryptococcal ink staining, and cryptococcal capsular polysaccharide antigen test were negative. Blood bacterial cultures were performed multiple times and all yielded negative. The results of CSF metagenomic next-generation sequencing (mNGS) suggested the presence of Mycobacterium tuberculosis (the nucleic acid standardized count was 108) and EBV(the nucleic acid standardized count was 126). Thus, the patient was diagnosed with TBM combine with adult EBV encephalitis, and immediately received acyclovir antiviral (dose 0.8g/day) treatment and intrathecal injection. After 3 days of active treatment, the patient’s consciousness gradually recovered, and the peak body temperature dropped to 38°C. One week later, the endotracheal tube was removed successfully, and the patient was weaned off the ventilator, maintaining a blood oxygen saturation of over 90% under oxygen inhalation. After 10 days of treatment, the patient’s temperature returned to normal, and the headache significantly relieved, with no obvious nausea and vomiting. After 1 month of treatment, the patient had no fever, headache, nausea, and vomiting. His consciousness was clear, with normal sleep and appetite, and normal urination and bowel movements. Follow-up craniocerebral MRI suggested the significant improvement in the right parietal lesion compared to admission (Figure 2). Repeat CSF examination suggested the normal pressure, significantly decreased CSF cell count and protein levels, and notably increased glucose and chloride levels.
Figure 2. (December 6th, 2023) MRI was performed after treatment. T1 (A), T2 (B), FLAIR (C), DWI (D), and ADC (E).The lesions were significantly improved and the edema was notably alleviated.
Discussion
The patient initially presented with a headache accompanied by a fever, which rapidly progressed to a coma. The clinical diagnosis of TBM was supported by CSF test results. Despite the administration of anti-tuberculosis medication and hormone therapy to reduce inflammatory response, along with alternative treatments, the patient remained in a comatose state with persistent elevated fever, indicating a worsening condition. mNGS of the CSF revealed concurrent infection of Mycobacterium tuberculosis and EBV. Immediate initiation of acyclovir antiviral therapy was administered. Following combined anti-tuberculosis and antiviral treatment, the patient’s consciousness improved, headache subsided, body temperature normalized, and disease progression was gradually controlled. This observation suggests that the patient was co-infected with both Mycobacterium tuberculosis and EBV rather than solely infected with Mycobacterium tuberculosis alone. After 37 days of anti-tuberculosis and antiviral therapy, complete resolution of clinical symptoms was achieved in the patient. Follow-up CSF examination demonstrated a significant decrease in cell counts and protein levels as well as a notable increase in glucose and chloride ion levels. Furthermore, brain MRI revealed evident absorption of the lesion located in the right parietal lobe.
TBM is a severe infectious disease of the central nervous system. It is the most destructive form of tuberculosis, accounting for approximately 5% - 10% of all extrapulmonary tuberculosis, and has a high mortality and disability rate (Donald, 2016; Daniel et al., 2019). The incidence of TBM varies greatly by region, and is influenced by the factors such as overall incidence of TB, age structure, and HIV seropositivity rate (van Crevel et al., 2016; Donovan et al., 2019). A large study including 57,217 cases of extrapulmonary TB showed that TBM constituted approximately 6% of all extrapulmonary TB cases (Donovan et al., 2019). The global burden of TBM is estimated to be at least over 100,000 new cases per year (Gomes et al., 2014). Study of the pathogenesis of TBM is hindered by the lack of experimental models that can reproduce all the characteristics of human disease. Currently, it is believed that the onset of TBM begins with respiratory tract infection, where Mycobacterium tuberculosis spreads to the central nervous system through the bloodstream, and grows and reproduces in individuals with compromised or defective immune function, eventually leading to clinical manifestation of the disease in patients (Meyer et al., 2006). TBM has a high mortality and disability rate, and its mortality soars to approximately 50% in patients coinfected with HIV (Prasad et al., 2016). With diversified clinical symptoms of TBM, non-specific CSF examination, insensitive Mycobacterium tuberculosis culture technique and long culture cycle, the diagnosis of TBM is extremely challenging, often resulting in delayed treatment, and extremely unfavorable prognosis for patients (Riste et al; Van and Farrar, 2013). In recent years, CSF metagenomic next-generation sequencing is a relatively accurate and rapid diagnostic method for TBM, widely used in clinical practice. metagenomic next-generation sequencing (mNGS) is a revolutionary technology that has emerged in recent years and can be used to conduct high-throughput sequencing of microbial nucleic acid in clinical samples and identify pathogens through comparison and analysis with standard sequences in the database. This technique has played an increasingly important clinical role in the diagnosis of CNS infections (Xiang et al., 2023).
EBV, also known as human herpesvirus type 4 (HHV-4), is a B-lymphotropic double-stranded DNA virus identified by Epstein Barr in 1964 (Johnson and Mims, 1968). Human are the only host of EBV, with children being more susceptible to infection. In adults, most EBV infection are asymptomatic, but in rare cases, clinical symptoms may manifest as EBV encephalitis, occurring in approximately 0.4% - 7.5% of cases (Abolhassani et al., 2016; Johnson et al., 2022). EBV primarily spreads through saliva, colonizing within the epithelium of the human body, and then infects B lymphocytes and enters the bloodstream, causing systemic infection (Kennedy, 2020). EBV encephalitis is clinically characterized by fever, headache, and meningeal irritation, and it lacks specificity when compared with other viral encephalitis (Piantadosi and Solomon, 2022; Mendoza et al., 2023). The pathogenesis of EBV encephalitis is currently believed to be related to direct virus invasion, immune induction after infection, and reactivation of immune function when suppressed after virus latency (Sanyal et al., 1991; Piret and Boivin, 2020). Clinical diagnosis of EBV encephalitis mainly depends on serum or CSF EBV-DNA detection and EBV-IgG antibody detection (Steiner and Benninger, 2013; Tselis, 2014). In this case, the patient tested positive EBV-IgG antibody in serum, and the mNGS of the CSF suggested EBV amplification, consistent with the diagnosis of EBV encephalitis.
Silicosis is a pneumoconiosis caused by the long-term inhalation of inorganic dust with high concentrations of free crystalline silica(SiO2),this interstitial lung disease is characterized by inflammation, formation of silicotic nodules, and fibrosis, which are progressive and irreversible (Handra et al., 2023; Ing and Kho, 2024). Alveolar macrophages, alveolar epithelial cells, and fibroblasts are involved in the complex pathogenesis of silicosis (Mayeux et al., 2018; Walters and Shukla, 2021). Studies investigating the pathogenesis of silicosis have focused on the roles of alveolar macrophages and alveolar epithelial cells, which secrete pro-inflammatory and profibrotic mediators secondary to exposure to silica, perpetuating the vicious cycle of tissue destruction (Martínez-López et al., 2023).
EBV infection is more common in children. In adults, when immune function is low, EBV lurking in the body can be activated and migrate, causing serious infections and various neurological complications (Tyler, 2018). Studies have demonstrated that EBV has the ability to directly invade neurons, as well as infect vascular endothelial cells and B lymphocytes within the intracranial region,this invasion leads to neurotoxicity through the release of inflammatory factors and viral proteins, ultimately resulting in a range of neurological disorders (Whitley and Gnann, 2002). However, the precise mechanism underlying EBV-mediated central nervous system injury remains incompletely elucidated (Liu et al., 2023).
Considering that the patient in this case had a clear silicosis in the past, we speculated that when the patient’s immune function was low, it might directly lead to the infection of mycobacterium tuberculosis and EBV, or the patient was complicated with hidden tuberculosis, and the migration and activation of mycobacterium tuberculosis and EBV were stimulated after the immune function was reduced, thus inducing a series of inflammatory reactions of the nervous system.
Conclusion
TBM in combination with EBV-infected adult meningoencephalitis is extremely rare clinically. Its early clinical symptoms are atypical and the condition is critical, with an severely elevated fatality rate. For such cases, timely and accurate clinical judgment, selection of appropriate tests, and prompt early diagnosis and appropriate treatment are critical in saving patients’ lives and reducing mortality and disability rates. NGS of CSF is of great value for early diagnosis.
Data availability statement
The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving humans were approved by Ethics Committee of the Affiliated Aerospace Hospital of Zunyi Medical University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
JW: Data curation, Formal analysis, Funding acquisition, Investigation, Writing – original draft, Writing – review & editing. ML: Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft. JZ: Formal analysis, Investigation, Methodology, Writing – original draft. LC: Formal analysis, Investigation, Project administration, Writing – original draft. PK: Data curation, Investigation, Project administration, Writing – original draft.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Science and Technology Fund Project of Guizhou Provincial Health Commission (gzwkj2023-109).
Acknowledgments
The authors are sincerely grateful for the support of the Department of Neurology, Affiliated Aerospace Hospital of Zunyi Medical University, in addition, we thank the patient and his family for agreeing to publish the case.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Abolhassani, H., Edwards, E. S. J., Ikinciogullari, A., Jing, H., Borte, S., Buggert, M., et al. (2016). Combined immunodeficiency and Epstein-Barr virus-induced B cell Malignancy in humans with inherited CD70 deficiency. J. Exp. Med. 214 (1), 39–44. doi: 10.1084/jem.20160849
Ahlawat, S., Chaudhary, R., Dangi, M., Bala, K., Singh, M., Chhillar, A. K. (2020). Advances in tuberculous meningitis diagnosis. Expert Rev. Mol. Diagn. 20 (12), 1229–1241. doi: 10.1080/14737159.2020.1858805
Baldwin, K. J., Cummings, C. L. (2018). Herpesvirus infections of the nervous system. Continuum (Minneap Minn) 24 (0), 1349–1369. doi: 10.1212/CON.0000000000000661
Daniel, B. D., Grace, G.A., Natrajan, M. (2019). Tuberculous meningitis in children: Clinical management & outcome. Indian J. Med. Res. 150 (2), 117–130. doi: 10.4103/ijmr.IJMR_786_17
Donald, P. R. (2016). Chemotherapy for tuberculous meningitis. N Engl. J. Med. 374 (2), 179–181. doi: 10.1056/NEJMe1511990
Donovan, J., Figaji, A., Imran, D., Phu, N. H., Rohlwink, U., Thwaites, G. E. (2019). The neurocritical care of tuberculous meningitis. Lancet Neurol. 18 (8), 771–783. doi: 10.1016/S1474-4422(19)30154-1
Gomes, T., Reis-Santos, B., Bertolde, A., Johnson, J. L., Riley, L. W., Maciel, E. L. (2014). Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model. BMC Infect. Dis. 14 (0), 9. doi: 10.1186/1471-2334-14-9
Handra, C.-M., Gurzu, I.-L., Chirila, M., Ghita, I. (2023). Silicosis: new challenges from an old inflammatory and fibrotic disease. Front. Biosci. (Landmark Ed) 28 (5), 96. doi: 10.31083/j.fbl2805096
Ing, S. K., Kho, S. S. (2024). Chronic silicosis. N Engl. J. Med. 390 (19), e46. doi: 10.1056/NEJMicm2312247
Johnson, I. M., Scheckel, C., Parikh, S. A., Enzler, M., Fugate, J., Call, T. G. (2022). Fatal Powassan virus encephalitis in patients with chronic lymphocytic leukemia. Blood Cancer J. 12 (10), 143. doi: 10.1038/s41408-022-00737-y
Johnson, R. T., Mims, C. A. (1968). Pathogenesis of viral infections of the nervous system. N Engl. J. Med. 278 (1), 23–30. doi: 10.1056/NEJM196801042780106
Kennedy, P. G.E. (2020). An overview of viral infections of the nervous system in the immunosuppressed. J. Neurol. 268 (8), 3026–3030. doi: 10.1007/s00415-020-10265-z
Liu, D., Lin, P.-H., Li, H.-L., Yang, J., You, Y., Yang, X., et al. (2023). Early autoimmunity and outcome in virus encephalitis: a retrospective study based on tissue-based assay. J. Neurol. Neurosurg. Psychiatry 94 (8), 605–613. doi: 10.1136/jnnp-2022-330626
Martínez-López, A., Candel, S., Tyrkalska, S. D. (2023). Animal models of silicosis: fishing for new therapeutic targets and treatments. Eur. Respir. Rev. 32 (169). doi: 10.1183/16000617.0078-2023
Mayeux, J. M., Escalante, G. M., Christy, J. M., Pawar, R. D., Kono, D. H., Pollard, K. M. (2018). Silicosis and silica-induced autoimmunity in the diversity outbred mouse. Front. Immunol. 9, 874. doi: 10.3389/fimmu.2018.00874
Mendoza, M. A., Hass, R. M., Vaillant, J., Johnson, D. R., Theel, E. S., Toledano, M., et al. (2023). Powassan virus encephalitis: A tertiary center experience. Clin. Infect. Dis. 78 (1), 80–89. doi: 10.1093/cid/ciad454
Meyer, S., Struffert, T., Gottschling, S. (2006). Tuberculous meningitis. Lancet 367 (9523), 1682. doi: 10.1016/S0140-6736(06)68736-9
Piantadosi, A., Solomon, I. H. (2022). Powassan virus encephalitis. Infect. Dis. Clin. North Am. 36 (3), 671–688. doi: 10.1016/j.idc.2022.03.003
Piret, J., Boivin, G. (2020). Immunomodulatory strategies in herpes simplex virus encephalitis. Clin. Microbiol. Rev. 33 (2). doi: 10.1128/CMR.00105-19
Prasad, K., Singh, M. B., Ryan, H. (2016). Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst. Rev. 4 (4), CD002244. doi: 10.1002/14651858.CD002244.pub4
Riste, M., Hobden, D., Pollard, C., Scriven, J. E. (2018). Diagnosis of tuberculous meningitis with invasive pulmonary sampling. Lancet Infect. Dis. 18 (1), 25–26. doi: 10.1016/S1473-3099(17)30713-2
Sanyal, D., Kudesia, G., Young, M. (1991). Epstein-Barr virus encephalitis. J. Infect. 22 (1), 101–102. doi: 10.1016/0163-4453(91)91290-e
Steiner, I., Benninger, F. (2013). Update on herpes virus infections of the nervous system. Curr. Neurol. Neurosci. Rep. 13 (12), 414. doi: 10.1007/s11910-013-0414-8
Tselis, A. C. (2014). Epstein-Barr virus infections of the nervous system. Handb. Clin. Neurol. 123, 285–305. doi: 10.1016/B978-0-444-53488-0.00013-4
Tyler, K. L. (2018). Acute viral encephalitis. N Engl. J. Med. 379 (6), 557–566. doi: 10.1056/NEJMra1708714
Van, T. T. T., Farrar, J. (2013). Tuberculous meningitis. J. Epidemiol. Community Health 68 (3), 195–196. doi: 10.1136/jech-2013-202525
van Crevel, R., Ruslami, R., Aarnoutse, R. (2016). Therapy for tuberculous meningitis. N Engl. J. Med. 374 (22), 2187. doi: 10.1056/NEJMc1602291
Walters, E. H., Shukla, S. D. (2021). Silicosis: Pathogenesis and utility of animal models of disease. Allergy 76 (10), 3241–3242. doi: 10.1111/all.14880
Whitley, R. J., Gnann, J. W. (2002). Viral encephalitis: familiar infections and emerging pathogens. Lancet 359 (9305), 507–513. doi: 10.1016/S0140-6736(02)07681-X
Xiang, Z.-B., Leng, E.-L., Cao, W.-F., Liu, S.-M., Zhou, Y.-L., Luo, C.-Q., et al. (2023). A systematic review and meta-analysis of the diagnostic accuracy of metagenomic next-generation sequencing for diagnosing tuberculous meningitis. Front. Immunol. 14 (0), 1223675. doi: 10.3389/fimmu.2023.1223675
Keywords: tuberculous meningitis, Epstein-Barr virus, meningoencephalitis, metagenomic next-generation sequencing, case report
Citation: Wang J, Li M, Zhu J, Cheng L and Kong P (2024) Mycobacterium tuberculosis combine with EBV infection in severe adult meningoencephalitis: a rare case reports and literature review. Front. Cell. Infect. Microbiol. 14:1361119. doi: 10.3389/fcimb.2024.1361119
Received: 08 January 2024; Accepted: 30 August 2024;
Published: 14 October 2024.
Edited by:
Alin Laurentiu Tatu, Dunarea de Jos University, RomaniaReviewed by:
Rizaldy Taslim Pinzon, Duta Wacana Christian University, IndonesiaBeatrice Paradiso, University of Milan, Italy
Copyright © 2024 Wang, Li, Zhu, Cheng and Kong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jian Wang, jack_w_szy@163.com